14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.48 $5.48 Wednesday, 24th Apr 2024 QURE stock ended at $4.56. This is 4.00% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 6.70% from a day low at $4.48 to a day high of $4.78.
90 days $4.48 $6.85
52 weeks $4.48 $22.48

Historical uniQure N.V. prices

Date Open High Low Close Volume
Mar 19, 2024 $4.97 $5.16 $4.95 $5.13 734 195
Mar 18, 2024 $5.26 $5.32 $4.95 $4.97 1 440 439
Mar 15, 2024 $4.82 $5.21 $4.76 $5.17 6 219 000
Mar 14, 2024 $5.11 $5.11 $4.80 $4.82 1 176 990
Mar 13, 2024 $5.15 $5.24 $5.02 $5.11 1 152 254
Mar 12, 2024 $5.22 $5.22 $4.90 $5.15 1 281 942
Mar 11, 2024 $5.21 $5.35 $5.11 $5.14 1 242 912
Mar 08, 2024 $5.32 $5.52 $5.13 $5.22 736 452
Mar 07, 2024 $5.18 $5.31 $5.13 $5.28 1 374 822
Mar 06, 2024 $5.03 $5.19 $4.98 $5.18 864 800
Mar 05, 2024 $5.11 $5.25 $5.01 $5.04 908 817
Mar 04, 2024 $5.53 $5.53 $5.10 $5.16 1 561 201
Mar 01, 2024 $5.81 $5.98 $5.47 $5.59 2 181 537
Feb 29, 2024 $6.12 $6.35 $5.53 $5.75 2 395 879
Feb 28, 2024 $6.79 $6.85 $6.38 $6.69 968 849
Feb 27, 2024 $6.50 $6.80 $6.23 $6.75 1 301 834
Feb 26, 2024 $6.35 $6.53 $6.23 $6.38 889 552
Feb 23, 2024 $6.28 $6.38 $6.14 $6.32 612 838
Feb 22, 2024 $6.28 $6.44 $6.23 $6.28 585 636
Feb 21, 2024 $6.24 $6.30 $6.08 $6.26 640 417
Feb 20, 2024 $5.85 $6.27 $5.78 $6.25 1 031 314
Feb 16, 2024 $5.47 $5.87 $5.36 $5.85 934 834
Feb 15, 2024 $5.33 $5.58 $5.33 $5.48 960 516
Feb 14, 2024 $5.42 $5.48 $5.21 $5.29 903 031
Feb 13, 2024 $5.71 $5.78 $5.32 $5.32 1 384 841
Click to get the best stock tips daily for free!

About uniQure N.V.

uniQure N.V. uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas... QURE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT